Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | CTSS | P25774 | 6/20 | 0.47 |
| ▸ | CTSK | P43235 | 6/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | GLS | O94925 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14737659 | 1.00 | KMT2A (0.53) | KMT2ACTSSCTSKCA1CA2 | |
| SCHEMBL3145509 | 1.00 | KMT2A (0.53) | KMT2ACTSSCTSKCA1CA2 | |
| SCHEMBL25413076 | 0.84 | KMT2A (0.51) | KMT2ACTSSCTSKCA1CA2 | |
| SCHEMBL25413081 | 0.84 | KMT2A (0.51) | KMT2ACTSSCTSKCA1CA2 | |
| SCHEMBL7403325 | 0.84 | KMT2A (0.51) | KMT2ACTSSCTSKCA1CA2 | |
| SCHEMBL26419810 | 0.83 | KMT2A (0.53) | KMT2ACTSSCTSKCA1CA2 | |
| SCHEMBL28827213 | 0.83 | KMT2A (0.53) | KMT2ACTSSCTSKCA1CA2 | |
| SCHEMBL10841914 | 0.83 | KMT2A (0.53) | KMT2ACTSSCTSKCA1CA2 | |
| SCHEMBL31517881 | 0.83 | KMT2A (0.56) | KMT2ACTSSCTSKCA1CA2 | |
| SCHEMBL2390418 | 0.83 | KMT2A (0.56) | KMT2ACTSSCTSKCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1917262-B1 | PIPERIDINE AND PIPERAZINE DERIVATIVES AS P2X3 ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2011-12-14 | — | — | EP | disclosed |